文献速递脑血管病外科神经重症

遗传性出血性毛细血管扩张症患者脑动静脉畸形的立体定向放射外科治疗

Stereotactic radiosurgery for brain arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia.
PubMed 文献 · Acta Neurochir (Wien) · 2024-01-17

该回顾性病例研究纳入8例遗传性出血性毛细血管扩张症(HHT)患者的14个脑动静脉畸形(AVM),接受立体定向放射外科(SRS)治疗。中位体积0.22 cm³,中位最大剂量36.2 Gy、边缘剂量20 Gy,总闭塞率11/14,症状性放射性改变7.1%且无永久性改变。作者认为SRS对HHT相关多发脑AVM总体有效且并发症率低,但需未来研究进一步明确其作用。

要点

  • HHT相关脑AVM多表现为小体积、低Spetzler-Martin分级(I-II级12/14)。
  • SRS后总闭塞率11/14,中位闭塞时间35.83个月。
  • 症状性放射性改变发生率7.1%,无永久性放射性改变,末次随访mRS均为0或1。

核心结论

  • HHT合并多发脑AVM的患者通常可从SRS治疗中获益,多数可实现闭塞且并发症率低。
  • 本研究中SRS前初始出血率值得关注,支持对这些AVM进行治疗的决策。
  • 未来需进一步研究以明确SRS在HHT患者破裂与未破裂AVM中的作用。

研究设计与样本

  • 回顾性病例研究,纳入8例HHT患者的14个脑AVM,收集临床、影像与治疗特征。
  • 作者称此为迄今接受SRS治疗的HHT患者最大系列。

主要发现

  • 中位AVM体积0.22 cm³(IQR 0.08-0.59)。
  • 8例患者中3例以初始脑出血(ICH)就诊。
  • 12/14个病灶为低Spetzler-Martin分级(I-II级)。
  • 中位最大剂量36.2 Gy(IQR 35.25-44.4),中位边缘剂量20 Gy(IQR 18-22.5)。
  • SRS后总闭塞率11/14,11个闭塞AVM的中位闭塞时间35.83个月(IQR 17-39.99)。

关键数值与推荐

  • 症状性放射性改变(RIC)发生率7.1%,无永久性RIC。
  • 末次随访所有患者mRS均为0或1。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Brain arteriovenous malformations (AVMs) in patients with hereditary hemorrhagic telangiectasia (HHT) present different characteristics from sporadic AVMs, and they have lower initial bleeding rates. Conservative management is usually preferred for the treatment of these lesions. In this case study, we present the largest series of HHT patients treated with stereotactic radiosurgery to date. METHODS: We identified eight patients with HHT and 14 AVMs. We retrospectively collected clinical, radiographic, and treatment characteristics of the patients and each AVM. RESULTS: Most patients in our sample presented with small AVMs. The median volume of these AVMs was 0.22 cm3 (IQR 0.08-0.59). Three out of eight patients presented with initial intracerebral hemorrhage (ICH). The majority of lesions had low (12/14) Spetzler-Martin grades (I-II). Median maximum and margin doses used for treatment were 36.2 (IQR 35.25-44.4) and 20 (IQR 18-22.5) Gy, respectively. The overall obliteration rate after SRS was 11/14, and the median time to obliteration across all 11 obliterated AVMs was 35.83 months (IQR, 17-39.99). Neurological status was favorable with all patients having a mRS of 0 or 1 at the last follow-up. Symptomatic radiation-induced changes (RIC) after SRS were low (7.1%), and there were no permanent RIC. CONCLUSIONS: Patients with HHT who present with multiple brain AVMs are generally well served by SRS. Obliteration can be achieved in the majority of HHT patients and with a low complication rate. In the current study, initial hemorrhage rates prior to SRS were noticeable which supports the decision to treat these AVMs. Future studies are needed to better address the role of SRS for HHT patients harboring ruptured and unruptured AVMs.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. González EO, Runge S, Mantziaris G, et al. Stereotactic radiosurgery for brain arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia. Acta Neurochir (Wien). 2024. PMID: 38231447. doi:10.1007/s00701-024-05923-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。